e-Health Program to Prevent Exacerbations in the Cystic Fibrosis Population - Trial NCT06313827
Access comprehensive clinical trial information for NCT06313827 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Valencia and is currently Not yet recruiting. The study focuses on Cystic Fibrosis. Target enrollment is 60 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Valencia
Timeline & Enrollment
N/A
Mar 01, 2024
Jun 01, 2025
Primary Outcome
Clinical exacerbation
Summary
The goal of this clinical trial is to analyse the impact of a telematic assessment and
 monitoring protocol in people with cystic fibrosis, in order to identify exacerbations early,
 thus preventing loss of lung function and maintaining quality of life.
 
 Participants will be assigned to one of 3 study groups:
 
 Control group (CG-1): will receive their usual physiotherapy treatment; Treatment group
 (TG-2): will receive their usual physiotherapy treatment, plus explanation of the use of the
 monitoring equipment; Treatment and follow-up group (TGF-3): will receive their usual
 physiotherapy treatment, plus explanation of the use of the monitoring equipment, plus
 telematic control of exacerbations with feedback from the physiotherapist.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06313827
Non-Device Trial